-
C646635-1mgCAY10650 is a highly potent cytosolic phospholipase A2α (cPLA2α) inhibitor with an IC 50 value of 12 nM. CAY10650 suppresses lipid droplets formation and PGE2 secretion.In VitroCAY10650 (12 nM: 30 min: neutrophils) inhibits the expression of the
-
C646635-50mgCAY10650 is a highly potent cytosolic phospholipase A2α (cPLA2α) inhibitor with an IC 50 value of 12 nM. CAY10650 suppresses lipid droplets formation and PGE2 secretion.In VitroCAY10650 (12 nM: 30 min: neutrophils) inhibits the expression of the
-
C646635-5mgCAY10650 is a highly potent cytosolic phospholipase A2α (cPLA2α) inhibitor with an IC 50 value of 12 nM. CAY10650 suppresses lipid droplets formation and PGE2 secretion.In VitroCAY10650 (12 nM: 30 min: neutrophils) inhibits the expression of the
-
C654671-1mlCAY10650 is a highly potent cytosolic phospholipase A2α (cPLA2α) inhibitor with an IC 50 value of 12 nM. CAY10650 suppresses lipid droplets formation and PGE2 secretion.In VitroCAY10650 (12 nM: 30 min: neutrophils) inhibits the expression of the
-
C649606-100mgCB-5339 is a potent p97 inhibitor with an IC 50 <:30 nM (WO2015109285A1, compound FF07).Form:Solid.
-
C649606-10mgCB-5339 is a potent p97 inhibitor with an IC 50 <:30 nM (WO2015109285A1, compound FF07).Form:Solid.
-
C649606-25mgCB-5339 is a potent p97 inhibitor with an IC 50 <:30 nM (WO2015109285A1, compound FF07).Form:Solid.
-
C649606-50mgCB-5339 is a potent p97 inhibitor with an IC 50 <:30 nM (WO2015109285A1, compound FF07).Form:Solid.
-
C649606-5mgCB-5339 is a potent p97 inhibitor with an IC 50 <:30 nM (WO2015109285A1, compound FF07).Form:Solid.
-
C655925-1mlCB-5339 is a potent p97 inhibitor with an IC 50 <:30 nM (WO2015109285A1, compound FF07).
-
C646311-10mgCB-7921220 is an adenylate cyclase inhibitor.In VitroCB-7921220 shows a degree of isoform selectivity for adenylate cyclase (AC) 1, but cannot distinguish between AC1 and AC6. CB-7921220 has a more consistent predicted binding position in the two
-
C646311-25mgCB-7921220 is an adenylate cyclase inhibitor.In VitroCB-7921220 shows a degree of isoform selectivity for adenylate cyclase (AC) 1, but cannot distinguish between AC1 and AC6. CB-7921220 has a more consistent predicted binding position in the two